Brookstone Capital Management trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 88.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,137 shares of the medical equipment provider’s stock after selling 32,570 shares during the quarter. Brookstone Capital Management’s holdings in Intuitive Surgical were worth $2,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also made changes to their positions in the company. Rakuten Investment Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $388,436,000. Assenagon Asset Management S.A. boosted its stake in shares of Intuitive Surgical by 106.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after buying an additional 791,516 shares during the period. Amundi grew its holdings in shares of Intuitive Surgical by 29.7% during the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares in the last quarter. Sands Capital Management LLC grew its holdings in shares of Intuitive Surgical by 77.0% during the 3rd quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after acquiring an additional 583,539 shares in the last quarter. Finally, Victory Capital Management Inc. increased its stake in shares of Intuitive Surgical by 41.3% in the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock worth $868,212,000 after acquiring an additional 567,483 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Trading Down 2.7%
Shares of NASDAQ:ISRG opened at $452.07 on Friday. The stock has a market capitalization of $160.54 billion, a PE ratio of 57.30, a P/E/G ratio of 3.58 and a beta of 1.68. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The firm has a fifty day moving average price of $488.87 and a 200 day moving average price of $512.97.
Key Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Motley Fool notes Intuitive “maintains edge” despite a March phishing breach — the report argues the incident exposed limited customer/contact data and does not materially impair the company’s core robotic-surgery platform or long-term growth thesis. Read More.
- Neutral Sentiment: The Zacks Analyst Blog flags mixed momentum for Intuitive alongside other large-cap names — the write-up highlights sector dynamics and does not change Intuitive’s longer-term narrative, but it signals cautious analyst tone. Read More.
- Neutral Sentiment: Kalkine Media reports a rating shift that put ISRG in focus on Nasdaq — the note drew trader attention but did not present new fundamental data; it likely amplified volatility as market participants reacted. Read More.
- Negative Sentiment: Coverage (Yahoo/Zacks) highlights growing pricing pressure in China as local rivals expand — analysts flag margin and unit-growth risk if Intuitive must defend share via pricing or increased commercial spend, even as the company leans on local manufacturing and its ecosystem to compete. Read More.
- Negative Sentiment: Zacks downgraded ISRG from “strong-buy” to “hold,” a direct analyst action that can prompt short-term selling and wider re-rating among momentum-driven investors. Read More.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Wells Fargo & Company upped their target price on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Royal Bank Of Canada lifted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Finally, Argus lowered their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $614.95.
View Our Latest Analysis on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In related news, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 in the last 90 days. Company insiders own 0.60% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
